References

1. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686 [CrossRef] [Google Scholar] [PubMed]
2. Woerther PL, Burdet C, Chachaty E, Andremont A (2013) Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 26: 744-758 [CrossRef] [Google Scholar] [PubMed]
3. Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas- Jean F, et al. (2013) 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 68: 562-568 [CrossRef] [Google Scholar] [PubMed]
4. Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, et al. (2014) Extendedspectrum- β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 58: 1228-1230 [CrossRef] [Google Scholar] [PubMed]
5. Kluytmans JA, Overdevest IT, Willemsen I, Kluytmans-van den Bergh MF, van der Zwaluw K, et al. (2013) Extended-spectrum beta-lactamaseproducing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 56: 478-487 [CrossRef] [Google Scholar] [PubMed]
6. Veldman K, van Tulden P, Kant A, Testerink J, Mevius D (2013) Characteristics of cefotaxime-resistant Escherichia coli from wild birds in the Netherlands. Appl Environ Microbiol 79: 7556-7561 [CrossRef] [Google Scholar] [PubMed]
7. Robberts FJ, Kohner PC, Patel R (2009) Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. J Clin Microbiol 47: 358-361 [CrossRef] [Google Scholar] [PubMed]
8. Jones CH, Tuckman M, Keeney D, Ruzin A, Bradford PA (2009) Characterization and sequence analysis of extended-spectrum-{beta}- lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials. Antimicrob Agents Chemother 53: 465-475 [CrossRef] [Google Scholar] [PubMed]
9. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH (2009) Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol 47: 2970-2974 [CrossRef] [Google Scholar] [PubMed]
10. Pitout JD, Hossain A, Hanson ND (2004) Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 42: 5715-5721 [CrossRef] [Google Scholar] [PubMed]
11. Lewis JS, 2nd, Herrera M, Wickes B, Patterson JE, Jorgensen JH (2007) First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 51 : 4015- [CrossRef] [Google Scholar] [PubMed]
12. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162 [CrossRef] [Google Scholar] [PubMed]
13. Mshana SE, Imirzalioglu C, Hossain H, Hain T, Domann E, et al. (2009) Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC Infect Dis 9:97 [CrossRef] [Google Scholar] [PubMed]
14. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Bottger EC, et al. (2012) Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum beta-lactamases (ESBL) in Enterobacteriaceae. Clin Microbiol Infect 18: 1194-1204 [CrossRef] [Google Scholar] [PubMed]
15. Wienke M, Pfeifer Y, Weissgerber P, Marschal M, Autenrieth IB, et al. (2012) In vitro activity of tigecycline and molecular characterization of extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany. Chemotherapy 58: 241-248 [CrossRef] [Google Scholar] [PubMed]
16. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN (2013) Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 57: 3012-3020 [CrossRef] [Google Scholar] [PubMed]
17. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, et al. (2013) Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 56: 641-648 [CrossRef] [Google Scholar] [PubMed]
18. Wang G, Huang T, Surendraiah PK, Wang K, Komal R, et al. (2013) CTX-M beta-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis 19: 1803-1810 [CrossRef] [Google Scholar] [PubMed]
19. Castanheira M, Farrell SE, Krause KM, Jones RN, Sader HS (2014) Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups. Antimicrob Agents Chemother 58: 833-838 [CrossRef] [Google Scholar] [PubMed]
20. Denisuik AJ, Lagace-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, et al. (2013) Molecular epidemiology of extended-spectrum beta-lactamase-, AmpC beta-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother 68 Suppl 1: i57-65 [CrossRef] [Google Scholar] [PubMed]
21. Canton R, Novais A, Valverde A, Machado E, Peixe L, et al. (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 14 Suppl 1:144-153 [CrossRef] [Google Scholar] [PubMed]
22. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, et al. (2006) Clinical and molecular epidemiology of extended-spectrum betalactamase- producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 42: 37-45 [CrossRef] [Google Scholar] [PubMed]
23. Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, et al. (2011) Risk factors and outcome of extended-spectrum β-lactamaseproducing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 37: 26-32 [CrossRef] [Google Scholar] [PubMed]
24. Seki LM, Pereira PS, de Souza Conceicao M, Souza MJ, Marques EA, et al. (2013) Molecular epidemiology of CTX-M producing Enterobacteriaceae isolated from bloodstream infections in Rio de Janeiro, Brazil: emergence of CTX-M-15. Braz J Infect Dis 7: 640-646 [CrossRef] [Google Scholar] [PubMed]
25. Huang S, Dai W, Sun S, Zhang X, Zhang L (2012) Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae. PLoS One 7: e47636 [CrossRef] [Google Scholar] [PubMed]
26. Tan TY1, Ng LS, He J, Hsu LY (2010) CTX-M and ampC beta-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore. Diagn Microbiol Infect Dis 66: 210-213 [CrossRef] [Google Scholar] [PubMed]
27. Fernández A, Gil E, Cartelle M, Pérez A, Beceiro A, et al. (2007) Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. J Antimicrob Chemother 59: 841-847 [CrossRef] [Google Scholar] [PubMed]
28. Gottig S, Gruber TM, Stecher B, Wichelhaus TA, Kempf VA (2015) In Vivo Horizontal Gene Transfer of the Carbapenemase OXA-48 During a Nosocomial Outbreak. Clin Infect Dis 60: 1808-1815 [CrossRef] [Google Scholar] [PubMed]
29. Doi Y, Adams-Haduch JM, Peleg AY, D'Agata EM (2012) The role of horizontal gene transfer in the dissemination of extended-spectrum betalactamase- producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. Diagn Microbiol Infect Dis 74: 34-38 [CrossRef] [Google Scholar] [PubMed]